William Blair initiated coverage of Definitive Healthcare with an Outperform rating and no price target. Definitive is a leading healthcare information technology provider of data and analytics solutions focused on healthcare commercial intelligence, the analyst tells investors in a research note. The firm believes the company offers a "differentiated" data and analytics platform with a compelling value proposition for clients across various market segments. It has a "durable long-term growth trajectory over the coming years," contends Blair.
Published first on TheFly
See the top stocks recommended by analysts >>
Read More on DH:
- Definitive Healthcare brings healthcare intelligence to Snowflake Marketplace
- Definitive Healthcare announces DefinitiveConnect on Salesforce AppExchange
- Definitive Healthcare brings healthcare commercial intelligence to Snowflake Marketplace
- Definitive Healthcare to Present at the Raymond James 2023 Institutional Investors Conference
- Definitive Healthcare sees FY23 adjusted EPS 19c-23c, consensus 23c